Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 293
Selected: 0
NCT IDTitle
NCT06213298Effect of Kava on Anxiety and Stress in Cancer Survivors
NCT00258362Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer
NCT02666105Exemestane in Post-Menopausal Women With NSCLC
NCT02693665Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer
NCT00889408DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma
NCT02161783Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation
NCT02118285Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00769990Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
NCT01666080Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
NCT00602446Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
NCT00652899Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer
NCT00855114Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
NCT00005998Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
NCT00346125PET CT as Predictor of Response in Preoperative Chemotherapy for Soft Tissue Sarcoma
NCT04204772A Pilot Feasibility Study of Activated Charcoal in Healthy Volunteers
NCT00290628Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT00354172Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers.
NCT00379197Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer
NCT00623077MT2004-30: Tomotherapy for Solid Tumors
NCT00895414Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer
NCT04284254MT2018-18: Sleeping Beauty Transposon-Engineered Plasmablasts for Hurler Syndrome Post Allo HSCT
NCT00428194Erlotinib, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB-Stage IVA Cervical Cancer
NCT04969783Telehealth-Filter Ventilation ( COMET2P1 )
NCT02046291Safety of Romiplostim (Nplate®) Following UCBT
NCT02074631Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation
NCT00630565Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00303719Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy
NCT01012362Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT00287859Topotecan in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00303667Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant
NCT00871689Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
NCT00888316Iron Overload in Patients Undergoing Donor Stem Cell Transplant
NCT00331422Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
NCT00176930Stem Cell Transplant for Hematological Malignancy
NCT00309842Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT01581970Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
NCT03417154Nivolumab and Oral Cyclophosphamide for R/R AML and HIgh Risk MDS
NCT00617188Fulvestrant in Treating Patients With Recurrent Ovarian Epithelial Cancer
NCT00005984Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia
NCT00618540Reduced Intensity Hematopoietic Cell Transplantation for Patients With Resistant Langerhans Cell Histiocytosis
NCT00369291CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT01560923Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer
NCT00167180Post Transplant Donor Lymphocyte Infusion
NCT04426669A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering
NCT00376519Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
NCT05363267NF-1, Nutraceutical Intervention